Clinical trials
Hepatic Encephalopathy trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital Universitari Vall d'Hebron Research Institute | 4 |
| Resolution Therapeutics Limited | 2 |
| Anna Baiges | 1 |
| Axcella Health, Inc | 1 |
| Bausch Health Americas, Inc. | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 1 |
| Hospital Clinic of Barcelona | 1 |
| Ocera Therapeutics, Inc. | 1 |
| Prof. Valérie Mc Lin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatic Encephalopathy | 14 |
| Fibrosis | 6 |
| Liver Cirrhosis | 6 |
| End Stage Liver Disease | 3 |
| Hyperammonemia | 2 |
| Sarcopenia | 2 |
| Ascites | 1 |
| Congenital Portosystemic Shunt | 1 |
| Esophageal and Gastric Varices | 1 |
| Gastrointestinal Hemorrhage | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.